nodes	percent_of_prediction	percent_of_DWPC	metapath
Estropipate—ALB—Vandetanib—thyroid cancer	0.212	0.434	CbGbCtD
Estropipate—CYP1A2—Sorafenib—thyroid cancer	0.0764	0.157	CbGbCtD
Estropipate—CYP2C9—Sorafenib—thyroid cancer	0.0688	0.141	CbGbCtD
Estropipate—CYP3A4—Vandetanib—thyroid cancer	0.0664	0.136	CbGbCtD
Estropipate—CYP3A4—Sorafenib—thyroid cancer	0.04	0.0821	CbGbCtD
Estropipate—CYP3A4—Doxorubicin—thyroid cancer	0.0243	0.0498	CbGbCtD
Estropipate—Dyspepsia—Vandetanib—thyroid cancer	0.00135	0.00322	CcSEcCtD
Estropipate—Vaginal haemorrhage—Doxorubicin—thyroid cancer	0.00134	0.0032	CcSEcCtD
Estropipate—Neuritis—Doxorubicin—thyroid cancer	0.00133	0.00317	CcSEcCtD
Estropipate—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00132	0.00316	CcSEcCtD
Estropipate—Fatigue—Vandetanib—thyroid cancer	0.00132	0.00315	CcSEcCtD
Estropipate—Angiopathy—Sorafenib—thyroid cancer	0.00132	0.00315	CcSEcCtD
Estropipate—Immune system disorder—Sorafenib—thyroid cancer	0.00131	0.00314	CcSEcCtD
Estropipate—Mediastinal disorder—Sorafenib—thyroid cancer	0.00131	0.00313	CcSEcCtD
Estropipate—Pain—Vandetanib—thyroid cancer	0.00131	0.00313	CcSEcCtD
Estropipate—Constipation—Vandetanib—thyroid cancer	0.00131	0.00313	CcSEcCtD
Estropipate—Alopecia—Sorafenib—thyroid cancer	0.00129	0.00307	CcSEcCtD
Estropipate—Mental disorder—Sorafenib—thyroid cancer	0.00128	0.00304	CcSEcCtD
Estropipate—Erythema—Sorafenib—thyroid cancer	0.00127	0.00302	CcSEcCtD
Estropipate—Malnutrition—Sorafenib—thyroid cancer	0.00127	0.00302	CcSEcCtD
Estropipate—Neoplasm malignant—Epirubicin—thyroid cancer	0.00125	0.00299	CcSEcCtD
Estropipate—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00125	0.00299	CcSEcCtD
Estropipate—Breast pain—Epirubicin—thyroid cancer	0.00123	0.00293	CcSEcCtD
Estropipate—Jaundice cholestatic—Epirubicin—thyroid cancer	0.00122	0.00291	CcSEcCtD
Estropipate—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00122	0.00291	CcSEcCtD
Estropipate—Amenorrhoea—Epirubicin—thyroid cancer	0.00122	0.00291	CcSEcCtD
Estropipate—Muscle spasms—Sorafenib—thyroid cancer	0.00122	0.00291	CcSEcCtD
Estropipate—Abdominal pain—Vandetanib—thyroid cancer	0.00121	0.00289	CcSEcCtD
Estropipate—Body temperature increased—Vandetanib—thyroid cancer	0.00121	0.00289	CcSEcCtD
Estropipate—Bone disorder—Epirubicin—thyroid cancer	0.00119	0.00283	CcSEcCtD
Estropipate—Cough increased—Epirubicin—thyroid cancer	0.00117	0.00279	CcSEcCtD
Estropipate—Hypocalcaemia—Epirubicin—thyroid cancer	0.00117	0.00279	CcSEcCtD
Estropipate—Neoplasm malignant—Doxorubicin—thyroid cancer	0.00116	0.00277	CcSEcCtD
Estropipate—Angioedema—Sorafenib—thyroid cancer	0.00116	0.00276	CcSEcCtD
Estropipate—Breast pain—Doxorubicin—thyroid cancer	0.00114	0.00271	CcSEcCtD
Estropipate—Jaundice cholestatic—Doxorubicin—thyroid cancer	0.00113	0.00269	CcSEcCtD
Estropipate—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00113	0.00269	CcSEcCtD
Estropipate—Amenorrhoea—Doxorubicin—thyroid cancer	0.00113	0.00269	CcSEcCtD
Estropipate—Cough—Sorafenib—thyroid cancer	0.00111	0.00264	CcSEcCtD
Estropipate—Inflammation—Epirubicin—thyroid cancer	0.0011	0.00264	CcSEcCtD
Estropipate—Asthenia—Vandetanib—thyroid cancer	0.0011	0.00262	CcSEcCtD
Estropipate—Bone disorder—Doxorubicin—thyroid cancer	0.0011	0.00262	CcSEcCtD
Estropipate—ESR1—Nuclear Receptors—RXRA—thyroid cancer	0.00109	0.0117	CbGpPWpGaD
Estropipate—ESR1—FOXM1 transcription factor network—CDK1—thyroid cancer	0.00109	0.0117	CbGpPWpGaD
Estropipate—Pruritus—Vandetanib—thyroid cancer	0.00108	0.00259	CcSEcCtD
Estropipate—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00108	0.00259	CcSEcCtD
Estropipate—Hypocalcaemia—Doxorubicin—thyroid cancer	0.00108	0.00258	CcSEcCtD
Estropipate—Cough increased—Doxorubicin—thyroid cancer	0.00108	0.00258	CcSEcCtD
Estropipate—ESR2—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.00108	0.0116	CbGpPWpGaD
Estropipate—Arthralgia—Sorafenib—thyroid cancer	0.00108	0.00257	CcSEcCtD
Estropipate—Myalgia—Sorafenib—thyroid cancer	0.00108	0.00257	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00107	0.00256	CcSEcCtD
Estropipate—Pulmonary embolism—Epirubicin—thyroid cancer	0.00107	0.00256	CcSEcCtD
Estropipate—Vaginal inflammation—Epirubicin—thyroid cancer	0.00107	0.00256	CcSEcCtD
Estropipate—Diarrhoea—Vandetanib—thyroid cancer	0.00105	0.0025	CcSEcCtD
Estropipate—Cystitis noninfective—Epirubicin—thyroid cancer	0.00105	0.0025	CcSEcCtD
Estropipate—CYP3A4—Liver X Receptor Pathway—RXRA—thyroid cancer	0.00104	0.0111	CbGpPWpGaD
Estropipate—Cystitis—Epirubicin—thyroid cancer	0.00103	0.00247	CcSEcCtD
Estropipate—Anaphylactic shock—Sorafenib—thyroid cancer	0.00103	0.00247	CcSEcCtD
Estropipate—Infection—Sorafenib—thyroid cancer	0.00103	0.00245	CcSEcCtD
Estropipate—CYP1A2—Arachidonic acid metabolism—HPGD—thyroid cancer	0.00103	0.011	CbGpPWpGaD
Estropipate—Inflammation—Doxorubicin—thyroid cancer	0.00102	0.00244	CcSEcCtD
Estropipate—Fluid retention—Epirubicin—thyroid cancer	0.00102	0.00243	CcSEcCtD
Estropipate—Nervous system disorder—Sorafenib—thyroid cancer	0.00101	0.00242	CcSEcCtD
Estropipate—Dizziness—Vandetanib—thyroid cancer	0.00101	0.00242	CcSEcCtD
Estropipate—Vaginal infection—Epirubicin—thyroid cancer	0.00101	0.00241	CcSEcCtD
Estropipate—ESR1—Estrogen signaling pathway—BRAF—thyroid cancer	0.001	0.0108	CbGpPWpGaD
Estropipate—Skin disorder—Sorafenib—thyroid cancer	0.001	0.0024	CcSEcCtD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—RET—thyroid cancer	0.001	0.0108	CbGpPWpGaD
Estropipate—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.001	0.00239	CcSEcCtD
Estropipate—Vaginal inflammation—Doxorubicin—thyroid cancer	0.000991	0.00237	CcSEcCtD
Estropipate—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000991	0.00237	CcSEcCtD
Estropipate—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000984	0.00235	CcSEcCtD
Estropipate—Vomiting—Vandetanib—thyroid cancer	0.000975	0.00233	CcSEcCtD
Estropipate—Neoplasm—Epirubicin—thyroid cancer	0.000968	0.00231	CcSEcCtD
Estropipate—Bladder pain—Epirubicin—thyroid cancer	0.000968	0.00231	CcSEcCtD
Estropipate—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000968	0.00231	CcSEcCtD
Estropipate—Rash—Vandetanib—thyroid cancer	0.000967	0.00231	CcSEcCtD
Estropipate—Dermatitis—Vandetanib—thyroid cancer	0.000966	0.0023	CcSEcCtD
Estropipate—ESR2—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000964	0.0103	CbGpPWpGaD
Estropipate—Headache—Vandetanib—thyroid cancer	0.00096	0.00229	CcSEcCtD
Estropipate—Cystitis—Doxorubicin—thyroid cancer	0.000957	0.00228	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000942	0.00225	CcSEcCtD
Estropipate—Fluid retention—Doxorubicin—thyroid cancer	0.000941	0.00225	CcSEcCtD
Estropipate—Hypertonia—Epirubicin—thyroid cancer	0.000939	0.00224	CcSEcCtD
Estropipate—Vaginal infection—Doxorubicin—thyroid cancer	0.000936	0.00223	CcSEcCtD
Estropipate—ESR1—Nuclear signaling by ERBB4—NRG1—thyroid cancer	0.000926	0.00993	CbGpPWpGaD
Estropipate—Nausea—Vandetanib—thyroid cancer	0.000911	0.00217	CcSEcCtD
Estropipate—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000911	0.00217	CcSEcCtD
Estropipate—Dyspepsia—Sorafenib—thyroid cancer	0.00091	0.00217	CcSEcCtD
Estropipate—Thrombophlebitis—Epirubicin—thyroid cancer	0.000898	0.00214	CcSEcCtD
Estropipate—Neoplasm—Doxorubicin—thyroid cancer	0.000896	0.00214	CcSEcCtD
Estropipate—Bladder pain—Doxorubicin—thyroid cancer	0.000896	0.00214	CcSEcCtD
Estropipate—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000893	0.00213	CcSEcCtD
Estropipate—Fatigue—Sorafenib—thyroid cancer	0.000892	0.00213	CcSEcCtD
Estropipate—Hepatic function abnormal—Epirubicin—thyroid cancer	0.00089	0.00212	CcSEcCtD
Estropipate—Constipation—Sorafenib—thyroid cancer	0.000884	0.00211	CcSEcCtD
Estropipate—Pain—Sorafenib—thyroid cancer	0.000884	0.00211	CcSEcCtD
Estropipate—Hypertonia—Doxorubicin—thyroid cancer	0.000869	0.00207	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—SST—thyroid cancer	0.000866	0.00929	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptor transcription pathway—RXRA—thyroid cancer	0.000864	0.00927	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000846	0.00202	CcSEcCtD
Estropipate—Thrombophlebitis—Doxorubicin—thyroid cancer	0.000831	0.00198	CcSEcCtD
Estropipate—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000823	0.00196	CcSEcCtD
Estropipate—Urticaria—Sorafenib—thyroid cancer	0.000822	0.00196	CcSEcCtD
Estropipate—Abdominal pain—Sorafenib—thyroid cancer	0.000817	0.00195	CcSEcCtD
Estropipate—Body temperature increased—Sorafenib—thyroid cancer	0.000817	0.00195	CcSEcCtD
Estropipate—Dermatitis bullous—Epirubicin—thyroid cancer	0.000814	0.00194	CcSEcCtD
Estropipate—Purpura—Epirubicin—thyroid cancer	0.000807	0.00193	CcSEcCtD
Estropipate—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000803	0.00192	CcSEcCtD
Estropipate—Cerebrovascular accident—Epirubicin—thyroid cancer	0.000793	0.00189	CcSEcCtD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.000789	0.00846	CbGpPWpGaD
Estropipate—Pain in extremity—Epirubicin—thyroid cancer	0.000778	0.00186	CcSEcCtD
Estropipate—Migraine—Epirubicin—thyroid cancer	0.000765	0.00183	CcSEcCtD
Estropipate—Hypersensitivity—Sorafenib—thyroid cancer	0.000762	0.00182	CcSEcCtD
Estropipate—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000753	0.0018	CcSEcCtD
Estropipate—Purpura—Doxorubicin—thyroid cancer	0.000746	0.00178	CcSEcCtD
Estropipate—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.000743	0.00177	CcSEcCtD
Estropipate—Asthenia—Sorafenib—thyroid cancer	0.000742	0.00177	CcSEcCtD
Estropipate—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—thyroid cancer	0.000742	0.00795	CbGpPWpGaD
Estropipate—Mood swings—Epirubicin—thyroid cancer	0.000737	0.00176	CcSEcCtD
Estropipate—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.000734	0.00175	CcSEcCtD
Estropipate—Pruritus—Sorafenib—thyroid cancer	0.000732	0.00175	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CDK1—thyroid cancer	0.000723	0.00775	CbGpPWpGaD
Estropipate—Pain in extremity—Doxorubicin—thyroid cancer	0.000719	0.00172	CcSEcCtD
Estropipate—Migraine—Doxorubicin—thyroid cancer	0.000708	0.00169	CcSEcCtD
Estropipate—Diarrhoea—Sorafenib—thyroid cancer	0.000708	0.00169	CcSEcCtD
Estropipate—Breast disorder—Epirubicin—thyroid cancer	0.000703	0.00168	CcSEcCtD
Estropipate—ESR2—Generic Transcription Pathway—THRB—thyroid cancer	0.000697	0.00747	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptors—PPARG—thyroid cancer	0.00069	0.0074	CbGpPWpGaD
Estropipate—ALB—Bile acid and bile salt metabolism—RXRA—thyroid cancer	0.000689	0.00739	CbGpPWpGaD
Estropipate—Dizziness—Sorafenib—thyroid cancer	0.000684	0.00163	CcSEcCtD
Estropipate—Mood swings—Doxorubicin—thyroid cancer	0.000682	0.00163	CcSEcCtD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.000679	0.00728	CbGpPWpGaD
Estropipate—Abdominal distension—Epirubicin—thyroid cancer	0.000677	0.00161	CcSEcCtD
Estropipate—Asthma—Epirubicin—thyroid cancer	0.000672	0.0016	CcSEcCtD
Estropipate—Influenza—Epirubicin—thyroid cancer	0.000672	0.0016	CcSEcCtD
Estropipate—Pancreatitis—Epirubicin—thyroid cancer	0.000659	0.00157	CcSEcCtD
Estropipate—Vomiting—Sorafenib—thyroid cancer	0.000658	0.00157	CcSEcCtD
Estropipate—Rash—Sorafenib—thyroid cancer	0.000652	0.00156	CcSEcCtD
Estropipate—Dermatitis—Sorafenib—thyroid cancer	0.000651	0.00155	CcSEcCtD
Estropipate—Breast disorder—Doxorubicin—thyroid cancer	0.00065	0.00155	CcSEcCtD
Estropipate—Headache—Sorafenib—thyroid cancer	0.000648	0.00155	CcSEcCtD
Estropipate—ESR2—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000641	0.00688	CbGpPWpGaD
Estropipate—Dysuria—Epirubicin—thyroid cancer	0.000628	0.0015	CcSEcCtD
Estropipate—Abdominal distension—Doxorubicin—thyroid cancer	0.000626	0.00149	CcSEcCtD
Estropipate—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000625	0.00149	CcSEcCtD
Estropipate—Asthma—Doxorubicin—thyroid cancer	0.000622	0.00148	CcSEcCtD
Estropipate—Influenza—Doxorubicin—thyroid cancer	0.000622	0.00148	CcSEcCtD
Estropipate—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000621	0.00666	CbGpPWpGaD
Estropipate—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.00062	0.00665	CbGpPWpGaD
Estropipate—Nausea—Sorafenib—thyroid cancer	0.000614	0.00147	CcSEcCtD
Estropipate—Weight increased—Epirubicin—thyroid cancer	0.000612	0.00146	CcSEcCtD
Estropipate—Pancreatitis—Doxorubicin—thyroid cancer	0.00061	0.00146	CcSEcCtD
Estropipate—Hyperglycaemia—Epirubicin—thyroid cancer	0.000606	0.00145	CcSEcCtD
Estropipate—Infestation NOS—Epirubicin—thyroid cancer	0.000599	0.00143	CcSEcCtD
Estropipate—Infestation—Epirubicin—thyroid cancer	0.000599	0.00143	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000596	0.00639	CbGpPWpGaD
Estropipate—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000587	0.0014	CcSEcCtD
Estropipate—Dysuria—Doxorubicin—thyroid cancer	0.000581	0.00139	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—thyroid cancer	0.00058	0.00622	CbGpPWpGaD
Estropipate—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000578	0.00138	CcSEcCtD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.000577	0.00619	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TPR—thyroid cancer	0.000577	0.00618	CbGpPWpGaD
Estropipate—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000567	0.00135	CcSEcCtD
Estropipate—Weight increased—Doxorubicin—thyroid cancer	0.000566	0.00135	CcSEcCtD
Estropipate—Sinusitis—Epirubicin—thyroid cancer	0.000562	0.00134	CcSEcCtD
Estropipate—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000561	0.00134	CcSEcCtD
Estropipate—Infestation—Doxorubicin—thyroid cancer	0.000554	0.00132	CcSEcCtD
Estropipate—Infestation NOS—Doxorubicin—thyroid cancer	0.000554	0.00132	CcSEcCtD
Estropipate—CYP2C9—Metapathway biotransformation—CHST14—thyroid cancer	0.000547	0.00587	CbGpPWpGaD
Estropipate—ESR1—Nuclear Receptor transcription pathway—PPARG—thyroid cancer	0.000546	0.00585	CbGpPWpGaD
Estropipate—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000543	0.0013	CcSEcCtD
Estropipate—Rhinitis—Epirubicin—thyroid cancer	0.000539	0.00129	CcSEcCtD
Estropipate—Pharyngitis—Epirubicin—thyroid cancer	0.000534	0.00127	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—TERT—thyroid cancer	0.000533	0.00572	CbGpPWpGaD
Estropipate—Oedema peripheral—Epirubicin—thyroid cancer	0.00053	0.00126	CcSEcCtD
Estropipate—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000524	0.00125	CcSEcCtD
Estropipate—ESR2—SIDS Susceptibility Pathways—HIF1A—thyroid cancer	0.00052	0.00558	CbGpPWpGaD
Estropipate—Sinusitis—Doxorubicin—thyroid cancer	0.00052	0.00124	CcSEcCtD
Estropipate—Visual impairment—Epirubicin—thyroid cancer	0.000518	0.00124	CcSEcCtD
Estropipate—ESR2—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000509	0.00546	CbGpPWpGaD
Estropipate—Erythema multiforme—Epirubicin—thyroid cancer	0.000509	0.00121	CcSEcCtD
Estropipate—Eye disorder—Epirubicin—thyroid cancer	0.000503	0.0012	CcSEcCtD
Estropipate—Cardiac disorder—Epirubicin—thyroid cancer	0.000499	0.00119	CcSEcCtD
Estropipate—Rhinitis—Doxorubicin—thyroid cancer	0.000499	0.00119	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—HIF1A—thyroid cancer	0.000498	0.00534	CbGpPWpGaD
Estropipate—Pharyngitis—Doxorubicin—thyroid cancer	0.000494	0.00118	CcSEcCtD
Estropipate—Oedema peripheral—Doxorubicin—thyroid cancer	0.00049	0.00117	CcSEcCtD
Estropipate—Angiopathy—Epirubicin—thyroid cancer	0.000488	0.00116	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—TRIM33—thyroid cancer	0.000486	0.00521	CbGpPWpGaD
Estropipate—Immune system disorder—Epirubicin—thyroid cancer	0.000486	0.00116	CcSEcCtD
Estropipate—Mediastinal disorder—Epirubicin—thyroid cancer	0.000485	0.00116	CcSEcCtD
Estropipate—Visual impairment—Doxorubicin—thyroid cancer	0.00048	0.00114	CcSEcCtD
Estropipate—Alopecia—Epirubicin—thyroid cancer	0.000475	0.00113	CcSEcCtD
Estropipate—Mental disorder—Epirubicin—thyroid cancer	0.000471	0.00112	CcSEcCtD
Estropipate—Erythema multiforme—Doxorubicin—thyroid cancer	0.000471	0.00112	CcSEcCtD
Estropipate—Erythema—Epirubicin—thyroid cancer	0.000468	0.00112	CcSEcCtD
Estropipate—Malnutrition—Epirubicin—thyroid cancer	0.000468	0.00112	CcSEcCtD
Estropipate—CYP1A2—Metapathway biotransformation—CHST14—thyroid cancer	0.000467	0.00501	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000466	0.005	CbGpPWpGaD
Estropipate—Eye disorder—Doxorubicin—thyroid cancer	0.000465	0.00111	CcSEcCtD
Estropipate—ESR2—Gene Expression—TRIM33—thyroid cancer	0.000464	0.00498	CbGpPWpGaD
Estropipate—Cardiac disorder—Doxorubicin—thyroid cancer	0.000462	0.0011	CcSEcCtD
Estropipate—Flatulence—Epirubicin—thyroid cancer	0.000461	0.0011	CcSEcCtD
Estropipate—Tension—Epirubicin—thyroid cancer	0.00046	0.0011	CcSEcCtD
Estropipate—Nervousness—Epirubicin—thyroid cancer	0.000455	0.00109	CcSEcCtD
Estropipate—Back pain—Epirubicin—thyroid cancer	0.000453	0.00108	CcSEcCtD
Estropipate—ESR1—FOXM1 transcription factor network—CCND1—thyroid cancer	0.000453	0.00486	CbGpPWpGaD
Estropipate—Angiopathy—Doxorubicin—thyroid cancer	0.000452	0.00108	CcSEcCtD
Estropipate—Muscle spasms—Epirubicin—thyroid cancer	0.00045	0.00107	CcSEcCtD
Estropipate—Immune system disorder—Doxorubicin—thyroid cancer	0.00045	0.00107	CcSEcCtD
Estropipate—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000449	0.00107	CcSEcCtD
Estropipate—ESR2—Generic Transcription Pathway—MEN1—thyroid cancer	0.000442	0.00475	CbGpPWpGaD
Estropipate—Alopecia—Doxorubicin—thyroid cancer	0.00044	0.00105	CcSEcCtD
Estropipate—Mental disorder—Doxorubicin—thyroid cancer	0.000436	0.00104	CcSEcCtD
Estropipate—Malnutrition—Doxorubicin—thyroid cancer	0.000433	0.00103	CcSEcCtD
Estropipate—Erythema—Doxorubicin—thyroid cancer	0.000433	0.00103	CcSEcCtD
Estropipate—Flatulence—Doxorubicin—thyroid cancer	0.000427	0.00102	CcSEcCtD
Estropipate—Tension—Doxorubicin—thyroid cancer	0.000425	0.00101	CcSEcCtD
Estropipate—Nervousness—Doxorubicin—thyroid cancer	0.000421	0.001	CcSEcCtD
Estropipate—Vertigo—Epirubicin—thyroid cancer	0.000421	0.001	CcSEcCtD
Estropipate—Back pain—Doxorubicin—thyroid cancer	0.000419	0.001	CcSEcCtD
Estropipate—Muscle spasms—Doxorubicin—thyroid cancer	0.000417	0.000994	CcSEcCtD
Estropipate—Palpitations—Epirubicin—thyroid cancer	0.000414	0.000988	CcSEcCtD
Estropipate—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000409	0.00439	CbGpPWpGaD
Estropipate—Cough—Epirubicin—thyroid cancer	0.000409	0.000975	CcSEcCtD
Estropipate—ESR1—Estrogen signaling pathway—AKT1—thyroid cancer	0.000408	0.00437	CbGpPWpGaD
Estropipate—Arthralgia—Epirubicin—thyroid cancer	0.000399	0.000951	CcSEcCtD
Estropipate—Myalgia—Epirubicin—thyroid cancer	0.000399	0.000951	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—NRAS—thyroid cancer	0.000398	0.00426	CbGpPWpGaD
Estropipate—Anxiety—Epirubicin—thyroid cancer	0.000397	0.000948	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000396	0.000945	CcSEcCtD
Estropipate—Vertigo—Doxorubicin—thyroid cancer	0.000389	0.000929	CcSEcCtD
Estropipate—ESR1—Signaling by ERBB4—CDK1—thyroid cancer	0.000389	0.00417	CbGpPWpGaD
Estropipate—Palpitations—Doxorubicin—thyroid cancer	0.000383	0.000914	CcSEcCtD
Estropipate—Anaphylactic shock—Epirubicin—thyroid cancer	0.000382	0.000912	CcSEcCtD
Estropipate—Oedema—Epirubicin—thyroid cancer	0.000382	0.000912	CcSEcCtD
Estropipate—Infection—Epirubicin—thyroid cancer	0.00038	0.000906	CcSEcCtD
Estropipate—Cough—Doxorubicin—thyroid cancer	0.000378	0.000902	CcSEcCtD
Estropipate—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000375	0.00402	CbGpPWpGaD
Estropipate—Nervous system disorder—Epirubicin—thyroid cancer	0.000375	0.000894	CcSEcCtD
Estropipate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000373	0.004	CbGpPWpGaD
Estropipate—Skin disorder—Epirubicin—thyroid cancer	0.000371	0.000886	CcSEcCtD
Estropipate—Myalgia—Doxorubicin—thyroid cancer	0.000369	0.00088	CcSEcCtD
Estropipate—Arthralgia—Doxorubicin—thyroid cancer	0.000369	0.00088	CcSEcCtD
Estropipate—Anxiety—Doxorubicin—thyroid cancer	0.000368	0.000877	CcSEcCtD
Estropipate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000366	0.000874	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000363	0.00389	CbGpPWpGaD
Estropipate—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000361	0.00387	CbGpPWpGaD
Estropipate—Oedema—Doxorubicin—thyroid cancer	0.000354	0.000844	CcSEcCtD
Estropipate—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000354	0.000844	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—THRB—thyroid cancer	0.000351	0.00377	CbGpPWpGaD
Estropipate—Infection—Doxorubicin—thyroid cancer	0.000351	0.000838	CcSEcCtD
Estropipate—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000348	0.000831	CcSEcCtD
Estropipate—Nervous system disorder—Doxorubicin—thyroid cancer	0.000347	0.000828	CcSEcCtD
Estropipate—Insomnia—Epirubicin—thyroid cancer	0.000346	0.000825	CcSEcCtD
Estropipate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—thyroid cancer	0.000345	0.0037	CbGpPWpGaD
Estropipate—ESR1—ATF-2 transcription factor network—CCND1—thyroid cancer	0.000345	0.0037	CbGpPWpGaD
Estropipate—Skin disorder—Doxorubicin—thyroid cancer	0.000343	0.00082	CcSEcCtD
Estropipate—Paraesthesia—Epirubicin—thyroid cancer	0.000343	0.000819	CcSEcCtD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—KRAS—thyroid cancer	0.000342	0.00367	CbGpPWpGaD
Estropipate—Somnolence—Epirubicin—thyroid cancer	0.00034	0.000811	CcSEcCtD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000337	0.00361	CbGpPWpGaD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000337	0.00361	CbGpPWpGaD
Estropipate—Dyspepsia—Epirubicin—thyroid cancer	0.000336	0.000803	CcSEcCtD
Estropipate—ESR2—Gene Expression—THRB—thyroid cancer	0.000335	0.0036	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00033	0.000787	CcSEcCtD
Estropipate—Fatigue—Epirubicin—thyroid cancer	0.000329	0.000786	CcSEcCtD
Estropipate—Pain—Epirubicin—thyroid cancer	0.000327	0.00078	CcSEcCtD
Estropipate—Constipation—Epirubicin—thyroid cancer	0.000327	0.00078	CcSEcCtD
Estropipate—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—thyroid cancer	0.000323	0.00347	CbGpPWpGaD
Estropipate—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000322	0.000769	CcSEcCtD
Estropipate—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00032	0.00344	CbGpPWpGaD
Estropipate—Insomnia—Doxorubicin—thyroid cancer	0.00032	0.000763	CcSEcCtD
Estropipate—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000319	0.00342	CbGpPWpGaD
Estropipate—Paraesthesia—Doxorubicin—thyroid cancer	0.000318	0.000758	CcSEcCtD
Estropipate—Somnolence—Doxorubicin—thyroid cancer	0.000314	0.00075	CcSEcCtD
Estropipate—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000313	0.000746	CcSEcCtD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000312	0.00335	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—NRG1—thyroid cancer	0.000312	0.00335	CbGpPWpGaD
Estropipate—Dyspepsia—Doxorubicin—thyroid cancer	0.000311	0.000743	CcSEcCtD
Estropipate—ESR1—Regulation of Telomerase—CCND1—thyroid cancer	0.000308	0.0033	CbGpPWpGaD
Estropipate—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000305	0.000729	CcSEcCtD
Estropipate—Fatigue—Doxorubicin—thyroid cancer	0.000305	0.000728	CcSEcCtD
Estropipate—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000304	0.00326	CbGpPWpGaD
Estropipate—Urticaria—Epirubicin—thyroid cancer	0.000304	0.000725	CcSEcCtD
Estropipate—Pain—Doxorubicin—thyroid cancer	0.000302	0.000722	CcSEcCtD
Estropipate—Constipation—Doxorubicin—thyroid cancer	0.000302	0.000722	CcSEcCtD
Estropipate—Body temperature increased—Epirubicin—thyroid cancer	0.000302	0.000721	CcSEcCtD
Estropipate—Abdominal pain—Epirubicin—thyroid cancer	0.000302	0.000721	CcSEcCtD
Estropipate—ESR1—AP-1 transcription factor network—CCND1—thyroid cancer	0.000301	0.00323	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.0003	0.00322	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—RXRA—thyroid cancer	0.000296	0.00317	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000296	0.00317	CbGpPWpGaD
Estropipate—ESR1—LKB1 signaling events—TP53—thyroid cancer	0.000293	0.00314	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—HRAS—thyroid cancer	0.000291	0.00312	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—PTEN—thyroid cancer	0.000291	0.00312	CbGpPWpGaD
Estropipate—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000289	0.00069	CcSEcCtD
Estropipate—ESR1—Leptin signaling pathway—CCND1—thyroid cancer	0.000285	0.00306	CbGpPWpGaD
Estropipate—Hypersensitivity—Epirubicin—thyroid cancer	0.000282	0.000672	CcSEcCtD
Estropipate—Urticaria—Doxorubicin—thyroid cancer	0.000281	0.00067	CcSEcCtD
Estropipate—Body temperature increased—Doxorubicin—thyroid cancer	0.00028	0.000667	CcSEcCtD
Estropipate—Abdominal pain—Doxorubicin—thyroid cancer	0.00028	0.000667	CcSEcCtD
Estropipate—Asthenia—Epirubicin—thyroid cancer	0.000274	0.000654	CcSEcCtD
Estropipate—Pruritus—Epirubicin—thyroid cancer	0.00027	0.000645	CcSEcCtD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000267	0.00287	CbGpPWpGaD
Estropipate—ESR1—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000265	0.00285	CbGpPWpGaD
Estropipate—Diarrhoea—Epirubicin—thyroid cancer	0.000261	0.000624	CcSEcCtD
Estropipate—Hypersensitivity—Doxorubicin—thyroid cancer	0.000261	0.000622	CcSEcCtD
Estropipate—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.00026	0.00279	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000258	0.00277	CbGpPWpGaD
Estropipate—ESR1—Plasma membrane estrogen receptor signaling—AKT1—thyroid cancer	0.000257	0.00275	CbGpPWpGaD
Estropipate—Asthenia—Doxorubicin—thyroid cancer	0.000254	0.000606	CcSEcCtD
Estropipate—Dizziness—Epirubicin—thyroid cancer	0.000253	0.000603	CcSEcCtD
Estropipate—SLC22A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000252	0.00271	CbGpPWpGaD
Estropipate—Pruritus—Doxorubicin—thyroid cancer	0.00025	0.000597	CcSEcCtD
Estropipate—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000247	0.00265	CbGpPWpGaD
Estropipate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000246	0.00264	CbGpPWpGaD
Estropipate—Vomiting—Epirubicin—thyroid cancer	0.000243	0.00058	CcSEcCtD
Estropipate—Diarrhoea—Doxorubicin—thyroid cancer	0.000242	0.000577	CcSEcCtD
Estropipate—Rash—Epirubicin—thyroid cancer	0.000241	0.000575	CcSEcCtD
Estropipate—Dermatitis—Epirubicin—thyroid cancer	0.000241	0.000575	CcSEcCtD
Estropipate—Headache—Epirubicin—thyroid cancer	0.000239	0.000571	CcSEcCtD
Estropipate—ESR1—Gene Expression—TRIM33—thyroid cancer	0.000234	0.00251	CbGpPWpGaD
Estropipate—Dizziness—Doxorubicin—thyroid cancer	0.000234	0.000558	CcSEcCtD
Estropipate—Nausea—Epirubicin—thyroid cancer	0.000227	0.000542	CcSEcCtD
Estropipate—ESR2—Gene Expression—TPR—thyroid cancer	0.000227	0.00243	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000225	0.00242	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000225	0.00242	CbGpPWpGaD
Estropipate—Vomiting—Doxorubicin—thyroid cancer	0.000225	0.000537	CcSEcCtD
Estropipate—ESR1—Generic Transcription Pathway—MEN1—thyroid cancer	0.000223	0.00239	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—BRAF—thyroid cancer	0.000223	0.00239	CbGpPWpGaD
Estropipate—Rash—Doxorubicin—thyroid cancer	0.000223	0.000532	CcSEcCtD
Estropipate—Dermatitis—Doxorubicin—thyroid cancer	0.000223	0.000532	CcSEcCtD
Estropipate—Headache—Doxorubicin—thyroid cancer	0.000222	0.000529	CcSEcCtD
Estropipate—SLC22A1—Metabolism—MINPP1—thyroid cancer	0.000217	0.00232	CbGpPWpGaD
Estropipate—CYP2C9—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000216	0.00231	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—MEN1—thyroid cancer	0.000213	0.00228	CbGpPWpGaD
Estropipate—Nausea—Doxorubicin—thyroid cancer	0.00021	0.000501	CcSEcCtD
Estropipate—ALB—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00021	0.00225	CbGpPWpGaD
Estropipate—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000201	0.00215	CbGpPWpGaD
Estropipate—ESR1—AP-1 transcription factor network—TP53—thyroid cancer	0.000198	0.00213	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000198	0.00213	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—thyroid cancer	0.000197	0.00211	CbGpPWpGaD
Estropipate—ESR2—Generic Transcription Pathway—PPARG—thyroid cancer	0.000187	0.002	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—NDUFA13—thyroid cancer	0.000184	0.00198	CbGpPWpGaD
Estropipate—CYP1A2—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.000184	0.00198	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—HRAS—thyroid cancer	0.000179	0.00192	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000176	0.00189	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—CHST14—thyroid cancer	0.000173	0.00186	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000172	0.00184	CbGpPWpGaD
Estropipate—ESR1—Regulation of Telomerase—AKT1—thyroid cancer	0.000171	0.00184	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000171	0.00184	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000171	0.00184	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—THRB—thyroid cancer	0.000169	0.00181	CbGpPWpGaD
Estropipate—ALB—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000169	0.00181	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000168	0.00181	CbGpPWpGaD
Estropipate—ALB—Selenium Micronutrient Network—PTGS2—thyroid cancer	0.000168	0.0018	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—CCND1—thyroid cancer	0.000163	0.00175	CbGpPWpGaD
Estropipate—CYP2C9—Biological oxidations—RXRA—thyroid cancer	0.000161	0.00173	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—BRAF—thyroid cancer	0.000161	0.00172	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CALCB—thyroid cancer	0.00016	0.00172	CbGpPWpGaD
Estropipate—ESR1—Leptin signaling pathway—AKT1—thyroid cancer	0.000158	0.0017	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—PTEN—thyroid cancer	0.000157	0.00168	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—PTEN—thyroid cancer	0.000156	0.00168	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—thyroid cancer	0.000153	0.00164	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TRIM33—thyroid cancer	0.000152	0.00163	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—RXRA—thyroid cancer	0.000149	0.0016	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000149	0.0016	CbGpPWpGaD
Estropipate—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—thyroid cancer	0.000149	0.0016	CbGpPWpGaD
Estropipate—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	0.000149	0.0016	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000147	0.00157	CbGpPWpGaD
Estropipate—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—thyroid cancer	0.000147	0.00157	CbGpPWpGaD
Estropipate—ALB—Metabolism—MINPP1—thyroid cancer	0.000145	0.00155	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—RXRA—thyroid cancer	0.000143	0.00153	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—HPGD—thyroid cancer	0.00014	0.0015	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—NRAS—thyroid cancer	0.000139	0.0015	CbGpPWpGaD
Estropipate—CYP1A2—Biological oxidations—RXRA—thyroid cancer	0.000138	0.00148	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000135	0.00145	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—thyroid cancer	0.000132	0.00141	CbGpPWpGaD
Estropipate—ALB—Hemostasis—PRKAR1A—thyroid cancer	0.00013	0.0014	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.00013	0.0014	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000128	0.00137	CbGpPWpGaD
Estropipate—ALB—Folate Metabolism—TP53—thyroid cancer	0.000126	0.00135	CbGpPWpGaD
Estropipate—ALB—Metabolism—NDUFA13—thyroid cancer	0.000123	0.00132	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—BRAF—thyroid cancer	0.000123	0.00132	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—KRAS—thyroid cancer	0.000121	0.00129	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—KRAS—thyroid cancer	0.00012	0.00129	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—MINPP1—thyroid cancer	0.000119	0.00127	CbGpPWpGaD
Estropipate—ALB—Metabolism—CHST14—thyroid cancer	0.000116	0.00124	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—CP—thyroid cancer	0.000115	0.00123	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000115	0.00123	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—TPR—thyroid cancer	0.000114	0.00123	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000113	0.00121	CbGpPWpGaD
Estropipate—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—thyroid cancer	0.000112	0.0012	CbGpPWpGaD
Estropipate—SLC22A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000108	0.00116	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—MEN1—thyroid cancer	0.000107	0.00115	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—TP53—thyroid cancer	0.000107	0.00115	CbGpPWpGaD
Estropipate—CYP3A4—Biological oxidations—RXRA—thyroid cancer	0.000107	0.00114	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—HRAS—thyroid cancer	0.000102	0.00109	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TCF7L1—thyroid cancer	0.000101	0.00109	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—MINPP1—thyroid cancer	0.000101	0.00109	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—NDUFA13—thyroid cancer	0.000101	0.00108	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	9.99e-05	0.00107	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—CHST14—thyroid cancer	9.48e-05	0.00102	CbGpPWpGaD
Estropipate—ESR1—Generic Transcription Pathway—PPARG—thyroid cancer	9.42e-05	0.00101	CbGpPWpGaD
Estropipate—ALB—Metabolism—HPGD—thyroid cancer	9.34e-05	0.001	CbGpPWpGaD
Estropipate—ESR1—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	9.05e-05	0.000971	CbGpPWpGaD
Estropipate—ESR1—Signaling by ERBB4—AKT1—thyroid cancer	9e-05	0.000966	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—PPARG—thyroid cancer	9e-05	0.000965	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	8.88e-05	0.000953	CbGpPWpGaD
Estropipate—ALB—Hemostasis—IFNA2—thyroid cancer	8.62e-05	0.000925	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—NDUFA13—thyroid cancer	8.62e-05	0.000925	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.57e-05	0.00092	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—CHST14—thyroid cancer	8.11e-05	0.000869	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—TPR—thyroid cancer	8.02e-05	0.00086	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PRKAR1A—thyroid cancer	7.89e-05	0.000846	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—MINPP1—thyroid cancer	7.82e-05	0.000839	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—HPGD—thyroid cancer	7.65e-05	0.00082	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.58e-05	0.000813	CbGpPWpGaD
Estropipate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	7.5e-05	0.000804	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TSHR—thyroid cancer	7.43e-05	0.000797	CbGpPWpGaD
Estropipate—SLC22A1—Transmission across Chemical Synapses—HRAS—thyroid cancer	7.39e-05	0.000793	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PRKAR1A—thyroid cancer	7.31e-05	0.000784	CbGpPWpGaD
Estropipate—ALB—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.2e-05	0.000773	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—RXRA—thyroid cancer	7.19e-05	0.000771	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—MEN1—thyroid cancer	6.98e-05	0.000749	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—NDUFA13—thyroid cancer	6.65e-05	0.000714	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—HPGD—thyroid cancer	6.53e-05	0.000701	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTCH1—thyroid cancer	6.32e-05	0.000677	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—CHST14—thyroid cancer	6.26e-05	0.000671	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	6.2e-05	0.000665	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—SLC5A5—thyroid cancer	6e-05	0.000644	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—SST—thyroid cancer	5.78e-05	0.00062	CbGpPWpGaD
Estropipate—SLC22A1—Neuronal System—HRAS—thyroid cancer	5.66e-05	0.000607	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CALCA—thyroid cancer	5.56e-05	0.000596	CbGpPWpGaD
Estropipate—ALB—Metabolism—TPR—thyroid cancer	5.36e-05	0.000575	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	5.3e-05	0.000568	CbGpPWpGaD
Estropipate—ALB—Metabolism—PRKAR1A—thyroid cancer	5.28e-05	0.000566	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—RXRA—thyroid cancer	5.04e-05	0.000541	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—HPGD—thyroid cancer	5.04e-05	0.000541	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CDK1—thyroid cancer	5.03e-05	0.00054	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.78e-05	0.000513	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—PPARG—thyroid cancer	4.54e-05	0.000487	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—TPR—thyroid cancer	4.39e-05	0.000471	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PRKAR1A—thyroid cancer	4.32e-05	0.000463	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRG1—thyroid cancer	4.04e-05	0.000433	CbGpPWpGaD
Estropipate—ALB—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	4.03e-05	0.000432	CbGpPWpGaD
Estropipate—ALB—Metabolism—SLC5A5—thyroid cancer	4.02e-05	0.000431	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.92e-05	0.00042	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.76e-05	0.000404	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—TPR—thyroid cancer	3.75e-05	0.000402	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PRKAR1A—thyroid cancer	3.69e-05	0.000396	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TERT—thyroid cancer	3.63e-05	0.000389	CbGpPWpGaD
Estropipate—ESR2—Gene Expression—AKT1—thyroid cancer	3.56e-05	0.000382	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HIF1A—thyroid cancer	3.47e-05	0.000372	CbGpPWpGaD
Estropipate—ALB—Metabolism—RXRA—thyroid cancer	3.37e-05	0.000362	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	3.35e-05	0.000359	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—SLC5A5—thyroid cancer	3.29e-05	0.000353	CbGpPWpGaD
Estropipate—ALB—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.28e-05	0.000352	CbGpPWpGaD
Estropipate—ALB—Hemostasis—NRAS—thyroid cancer	3.22e-05	0.000345	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PPARG—thyroid cancer	3.18e-05	0.000342	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.08e-05	0.00033	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—TPR—thyroid cancer	2.9e-05	0.000311	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—BRAF—thyroid cancer	2.87e-05	0.000308	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	2.85e-05	0.000306	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—SLC5A5—thyroid cancer	2.81e-05	0.000301	CbGpPWpGaD
Estropipate—ALB—Hemostasis—KRAS—thyroid cancer	2.77e-05	0.000297	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—RXRA—thyroid cancer	2.76e-05	0.000296	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.69e-05	0.000288	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.63e-05	0.000282	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTGS2—thyroid cancer	2.51e-05	0.000269	CbGpPWpGaD
Estropipate—ALB—Hemostasis—TP53—thyroid cancer	2.46e-05	0.000264	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—RXRA—thyroid cancer	2.36e-05	0.000253	CbGpPWpGaD
Estropipate—ALB—Hemostasis—HRAS—thyroid cancer	2.35e-05	0.000252	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	2.3e-05	0.000246	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—PTEN—thyroid cancer	2.18e-05	0.000234	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—SLC5A5—thyroid cancer	2.17e-05	0.000233	CbGpPWpGaD
Estropipate—ALB—Metabolism—PPARG—thyroid cancer	2.13e-05	0.000228	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—CCND1—thyroid cancer	2.1e-05	0.000225	CbGpPWpGaD
Estropipate—ALB—Hemostasis—AKT1—thyroid cancer	2.08e-05	0.000223	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—PTEN—thyroid cancer	2.02e-05	0.000217	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—RXRA—thyroid cancer	1.82e-05	0.000195	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—NRAS—thyroid cancer	1.81e-05	0.000194	CbGpPWpGaD
Estropipate—ESR1—Gene Expression—AKT1—thyroid cancer	1.79e-05	0.000192	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PPARG—thyroid cancer	1.74e-05	0.000187	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTGS2—thyroid cancer	1.68e-05	0.00018	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—KRAS—thyroid cancer	1.55e-05	0.000167	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PPARG—thyroid cancer	1.49e-05	0.00016	CbGpPWpGaD
Estropipate—ALB—Metabolism—PTEN—thyroid cancer	1.46e-05	0.000157	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—TP53—thyroid cancer	1.38e-05	0.000148	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTGS2—thyroid cancer	1.37e-05	0.000147	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—HRAS—thyroid cancer	1.32e-05	0.000142	CbGpPWpGaD
Estropipate—SLC22A1—Metabolism—AKT1—thyroid cancer	1.26e-05	0.000135	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—PTEN—thyroid cancer	1.2e-05	0.000128	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTGS2—thyroid cancer	1.17e-05	0.000126	CbGpPWpGaD
Estropipate—ESR1—Signaling Pathways—AKT1—thyroid cancer	1.17e-05	0.000125	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PPARG—thyroid cancer	1.15e-05	0.000123	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—PTEN—thyroid cancer	1.02e-05	0.00011	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTGS2—thyroid cancer	9.05e-06	9.7e-05	CbGpPWpGaD
Estropipate—ALB—Metabolism—AKT1—thyroid cancer	8.42e-06	9.03e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—PTEN—thyroid cancer	7.89e-06	8.46e-05	CbGpPWpGaD
Estropipate—CYP2C9—Metabolism—AKT1—thyroid cancer	6.89e-06	7.39e-05	CbGpPWpGaD
Estropipate—CYP1A2—Metabolism—AKT1—thyroid cancer	5.89e-06	6.32e-05	CbGpPWpGaD
Estropipate—CYP3A4—Metabolism—AKT1—thyroid cancer	4.55e-06	4.88e-05	CbGpPWpGaD
